Vaxcyte Inc
NASDAQ:PCVX 11:29:34 AM EDT
Earnings Announcements
Vaxcyte Posts Quarterly Loss Per Share $0.68
Published: 05/09/2022 21:34 GMT
Vaxcyte Inc (PCVX) - Vaxcyte Reports First Quarter 2022 Financial Results and Provides Business Update.
Vaxcyte Inc - $352.3 Million in Cash, Cash Equivalents and Investments As of March 31, 2022.
Vaxcyte Inc Qtrly Loss per Share $0.68.
Vaxcyte Inc - $352.3 Million in Cash, Cash Equivalents and Investments As of March 31, 2022.
Vaxcyte Inc Qtrly Loss per Share $0.68.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.65
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.68
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.65
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.68
More details on our Analysts Page.